The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ketalar 50 mg/ml Solution for Injection/Infusion



Pfizer Healthcare IrelandPA0822/013/002

Main Information

Trade NameKetalar 50 mg/ml Solution for Injection/Infusion
Active SubstancesKetamine hydrochloride
Dosage FormSolution for injection/infusion
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/013/002

Group Information

ATC CodeN01AX Other general anesthetics
N01AX03 ketamine

Status

License statusAuthorised
Licence Issued01/04/1980
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in Schedule 3(2) to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back